UK CMA Issues £70m Fines To Pfizer And Flynn Over Phenytoin

Competition Regulator Finds Firms Abused Dominant Position To Overcharge NHS

CMA
The CMA has reassessed part of the case • Source: Shutterstock

More from Legal & IP

More from Pink Sheet